Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
September 11, 2007
Sensitive high-performance liquid chromatography-tandem mass spectrometry method for quantitative analysis of mycophenolic acid and its glucuronide metabolites in human plasma and urine
Marie-Odile Benoit-Biancamano, Patrick Caron, Eric Lévesque, et al.
Current Oncology (Toronto, Ont.)
|
August 27, 2025
Pembrolizumab-Induced Simultaneous and Refractory Systemic Capillary Leak and Cytokine Release Syndromes: A Case Report
Eugénie Roberge-Maltais, Eric Lévesque, Vincent Castonguay, et al.
Pharmacogenetics and Genomics
|
February 9, 2010
Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidation
Eric Lévesque, Vincent Ménard, Isabelle Laverdière, et al.
Pharmacogenetics and Genomics
|
October 17, 2013
Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer
Vincent Ménard, Eric Lévesque, Sylvia Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2014
Steroidogenic germline polymorphism predictors of prostate cancer progression in the estradiol pathway
Eric Lévesque, Isabelle Laverdière, Etienne Audet-Walsh, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 7, 2013
Refining the UGT1A haplotype associated with irinotecan-induced hematological toxicity in metastatic colorectal cancer patients treated with 5-fluorouracil/irinotecan-based regimens
Eric Lévesque, Anne-Sophie Bélanger, Mario Harvey, et al.
Frontiers in Oncology
|
July 24, 2019
Inactivation of Prostaglandin E<sub>2</sub> as a Mechanism for UGT2B17-Mediated Adverse Effects in Chronic Lymphocytic Leukemia
Eric P Allain, Michèle Rouleau, Trang Le, et al.
Pharmacogenetics and Genomics
|
September 10, 2015
ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients
Sylvia Chen, Lyne Villeneuve, Derek Jonker, et al.
The Journal of Urology
|
November 15, 2024
High 11-Ketotestosterone Linked to Shorter Time to Castration Resistance in Recurrent Nonmetastatic Prostate Cancer
Cylia Dahmani, Patrick Caron, David Simonyan, et al.
The Journal of Urology
|
November 14, 2022
Preoperative Circulating 11-Oxygenated Androgens Are Associated With Metastasis-free Survival in Localized Prostate Cancer
Cylia Dahmani, Patrick Caron, David Simonyan, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
September 11, 2007
Sensitive high-performance liquid chromatography-tandem mass spectrometry method for quantitative analysis of mycophenolic acid and its glucuronide metabolites in human plasma and urine
Marie-Odile Benoit-Biancamano, Patrick Caron, Eric Lévesque, et al.
Current Oncology (Toronto, Ont.)
|
August 27, 2025
Pembrolizumab-Induced Simultaneous and Refractory Systemic Capillary Leak and Cytokine Release Syndromes: A Case Report
Eugénie Roberge-Maltais, Eric Lévesque, Vincent Castonguay, et al.
Pharmacogenetics and Genomics
|
February 9, 2010
Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidation
Eric Lévesque, Vincent Ménard, Isabelle Laverdière, et al.
Pharmacogenetics and Genomics
|
October 17, 2013
Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer
Vincent Ménard, Eric Lévesque, Sylvia Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2014
Steroidogenic germline polymorphism predictors of prostate cancer progression in the estradiol pathway
Eric Lévesque, Isabelle Laverdière, Etienne Audet-Walsh, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 7, 2013
Refining the UGT1A haplotype associated with irinotecan-induced hematological toxicity in metastatic colorectal cancer patients treated with 5-fluorouracil/irinotecan-based regimens
Eric Lévesque, Anne-Sophie Bélanger, Mario Harvey, et al.
Frontiers in Oncology
|
July 24, 2019
Inactivation of Prostaglandin E<sub>2</sub> as a Mechanism for UGT2B17-Mediated Adverse Effects in Chronic Lymphocytic Leukemia
Eric P Allain, Michèle Rouleau, Trang Le, et al.
Pharmacogenetics and Genomics
|
September 10, 2015
ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients
Sylvia Chen, Lyne Villeneuve, Derek Jonker, et al.
The Journal of Urology
|
November 15, 2024
High 11-Ketotestosterone Linked to Shorter Time to Castration Resistance in Recurrent Nonmetastatic Prostate Cancer
Cylia Dahmani, Patrick Caron, David Simonyan, et al.
The Journal of Urology
|
November 14, 2022
Preoperative Circulating 11-Oxygenated Androgens Are Associated With Metastasis-free Survival in Localized Prostate Cancer
Cylia Dahmani, Patrick Caron, David Simonyan, et al.
Page
of 4